BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaplan BS, Cleary TG, Obrig TG. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 1990;4:276-83. [DOI: 10.1007/bf00857676] [Cited by in Crossref: 83] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Louise CB, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 1992;60:1536-43. [PMID: 1548077 DOI: 10.1128/iai.60.4.1536-1543.1992] [Cited by in Crossref: 98] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
2 Bogdanović R, Cobeljić M, Marković M, Nikolić V, Ognjanović M, Sarjanović L, Makić D. Haemolytic-uraemic syndrome associated with Aeromonas hydrophila enterocolitis. Pediatr Nephrol 1991;5:293-5. [PMID: 1867983 DOI: 10.1007/BF00867480] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
3 Brandelli JR, Griener TP, Laing A, Mulvey G, Armstrong GD. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells. Toxins (Basel) 2015;7:4054-66. [PMID: 26473922 DOI: 10.3390/toxins7104054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
4 Palermo MS, Alves Rosa MF, Van Rooijen N, Isturiz MA. Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol 1999;116:462-7. [PMID: 10361235 DOI: 10.1046/j.1365-2249.1999.00925.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
5 Taylor CM, Milford DV, White RH. A plea for standardized terminology within the haemolytic uraemic syndromes. Pediatr Nephrol 1991;5:97. [PMID: 2025550 DOI: 10.1007/BF00852859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Rowe PC. Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood. Can J Infect Dis 1995;6:105-10. [PMID: 22416211 DOI: 10.1155/1995/803560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Russo LM, Melton-Celsa AR, Smith MA, Smith MJ, O'Brien AD. Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10. Infect Immun 2014;82:1213-21. [PMID: 24379294 DOI: 10.1128/IAI.01264-13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
8 Bitzan M, Ludwig K, Klemt M, König H, Büren J, Müller-Wiefel DE. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect 1993;110:183-96. [PMID: 8472763 DOI: 10.1017/s0950268800068102] [Cited by in Crossref: 80] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
9 Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 2006;108:167-76. [PMID: 16514062 DOI: 10.1182/blood-2005-08-3219] [Cited by in Crossref: 138] [Cited by in F6Publishing: 131] [Article Influence: 8.6] [Reference Citation Analysis]
10 Song L, Xiao Y, Li X, Huang Y, Meng G, Ren Z. Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model. Front Immunol 2020;11:619096. [PMID: 33552083 DOI: 10.3389/fimmu.2020.619096] [Reference Citation Analysis]
11 Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN. A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect 1993;110:1-7. [PMID: 8432313 DOI: 10.1017/s0950268800050615] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
12 Maroeska Te Loo D, Bosma N, Van Hinsbergh V, Span P, De Waal R, Clarijs R, Sweep C, Monnens L, Van Den Heuvel L. Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS. Pediatr Nephrol 2004;19:754-60. [PMID: 15141341 DOI: 10.1007/s00467-004-1475-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
13 Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH. Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 2000;6:530-3. [PMID: 10998385 DOI: 10.3201/eid0605.000513] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 4.0] [Reference Citation Analysis]
14 Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996;10:88-99. [PMID: 8611369 DOI: 10.1007/BF00863459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
15 Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T, Gear AR. Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun 2005;73:8306-16. [PMID: 16299328 DOI: 10.1128/IAI.73.12.8306-8316.2005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
16 Heuvelink AE, van de Kar NC, Meis JF, Monnens LA, Melchers WJ. Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect 1995;115:1-14. [PMID: 7641823 DOI: 10.1017/s0950268800058064] [Cited by in Crossref: 59] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
17 Kioka N, Minami K, Tamura A, Yoshikawa N. Chemokine expression in human astrocytes in response to shiga toxin 2. Int J Inflam 2012;2012:135803. [PMID: 23304632 DOI: 10.1155/2012/135803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Eisenhauer PB, Chaturvedi P, Fine RE, Ritchie AJ, Pober JS, Cleary TG, Newburg DS. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 2001;69:1889-94. [PMID: 11179369 DOI: 10.1128/IAI.69.3.1889-1894.2001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
19 Obrig TG. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2010;2:2769-94. [PMID: 21297888 DOI: 10.3390/toxins2122769] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
20 Pan CG, Leichter HE, Werlin SL. Hepatocellular injury in Streptococcus pneumoniae-associated hemolytic uremic syndrome in children. Pediatr Nephrol 1995;9:690-3. [PMID: 8747106 DOI: 10.1007/BF00868713] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
21 Voyer LE, Wainsztein RE, Quadri BE, Corti SE. Hemolytic uremic syndrome in families-an Argentinian experience. Pediatr Nephrol 1996;10:70-2. [PMID: 8611362 DOI: 10.1007/BF00863451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]